arrow_back Back to App

Maintaining Drug Discounts for Hospitals During COVID-19 Pandemic.

This act allows hospitals that participated in or applied for a drug discount program before the COVID-19 pandemic to temporarily maintain their eligibility. This helps hospitals continue to purchase medications at lower prices, potentially contributing to sustained access to drugs and reduced healthcare costs for patients during a challenging period.
Key points
Hospitals already in the drug discount program before COVID-19 can continue to participate, even if they temporarily don't meet all regular requirements.
This also applies to hospitals that applied for the program before the pandemic and were approved.
The goal is to ensure hospitals maintain access to cheaper medications, which can lead to lower treatment costs for patients.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_773
Sponsor: Sen. Thune, John [R-SD]
Process start date: 2021-03-16
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_773.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-03-16.

What are the main provisions?

Key points include:

  • Hospitals already in the drug discount program before COVID-19 can continue to participate, even if they temporarily don't meet all regular requirements.
  • This also applies to hospitals that applied for the program before the pandemic and were approved.
  • The goal is to ensure hospitals maintain access to cheaper medications, which can lead to lower treatment costs for patients.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Thune, John [R-SD].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health